We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Data Visualization in Biopharma: Leveraging AI, VR and MR to Support Drug Discovery

Article   Jun 12, 2019 | by Nimita Limaye, PhD

 
Data Visualization in Biopharma: Leveraging AI, VR and MR to Support Drug Discovery
 
 
Advertisement
 

RELATED ARTICLES

A New Way To Characterize Glycans From SARS-CoV-2's Spike Protein

Article

Dr Rod Chalk, head of mass spectrometry at The Centre for Medicines Discovery (previously the Structural Genomics Consortium) has developed a novel mass spectrometry-based method for characterizing glycans from the Spike protein. In this interview, Chalk discusses the method and how it can be adopted in SARS-CoV-2 research and beyond.

READ MORE

Stay Up-to-Date With COVID-19 Drug Development

Article

Whilst the world waits for an effective COVID-19 vaccine to be developed, researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE